A patient newly started on a medication with capsules that must not be opened due to risk of overdose. Which drug is most likely?

A patient newly started on a medication with capsules that must not be opened due to risk of overdose. Which drug is most likely?

• A. Dabigatran
• B. Warfarin
• C. Rivaroxaban
• D. Apixaban

Answer: (A)

The key concept is that some drugs are designed so the capsule must be swallowed whole to ensure predictable absorption and avoid dangerous overdose. Dabigatran comes as capsules that should not be opened; opening them can release the drug powder in an uncontrolled way, leading to higher and faster absorption and a greater risk of bleeding from overdosing. The capsule also contains components (such as an acidic environment) that aid absorption, so breaking the capsule disrupts this controlled delivery. Warfarin, rivaroxaban, and apixaban are used in tablet forms, not capsules, and do not carry the same explicit instruction about not opening; thus the capsule-specific safety note points to dabigatran as the most likely drug in this scenario.

The key concept is that some drugs are designed so the capsule must be swallowed whole to ensure predictable absorption and avoid dangerous overdose. Dabigatran comes as capsules that should not be opened; opening them can release the drug powder in an uncontrolled way, leading to higher and faster absorption and a greater risk of bleeding from overdosing. The capsule also contains components (such as an acidic environment) that aid absorption, so breaking the capsule disrupts this controlled delivery. Warfarin, rivaroxaban, and apixaban are used in tablet forms, not capsules, and do not carry the same explicit instruction about not opening; thus the capsule-specific safety note points to dabigatran as the most likely drug in this scenario.